anti-TNFRSF10A (TNFRSF10A) Antikörper

Bezeichnung:
anti-Tumor Necrosis Factor Receptor Superfamily, Member 10a Antikörper (TNFRSF10A)
Auf www.antikoerper-online.de finden Sie aktuell 299 Tumor Necrosis Factor Receptor Superfamily, Member 10a (TNFRSF10A) Antikörper von 24 unterschiedlichen Herstellern. Zusätzlich bieten wir Ihnen TNFRSF10A Proteine (21) und TNFRSF10A Kits (15) und viele weitere Produktgruppen zu diesem Protein an. Insgesamt sind aktuell 341 TNFRSF10A Produkte verfügbar.
Synonyme:
APO2, CD261, DR4, TNFRSF10A, TRAILR-1, TRAILR1
Alle Antikörper anzeigen Gen GeneID UniProt
TNFRSF10A 8797 O00220
TNFRSF10A    
TNFRSF10A    

Alle Spezies anzeigen

Weitere Synonyme anzeigen

Meistgesuchte Reaktivitäten zu anti-TNFRSF10A (TNFRSF10A) Antikörper

Wählen Sie die Spezies und Applikation aus

anti-Human TNFRSF10A Antikörper:

anti-Mouse (Murine) TNFRSF10A Antikörper:

anti-Rat (Rattus) TNFRSF10A Antikörper:

Alle verfügbaren anti-TNFRSF10A Antikörper

Sie gelangen zu unserer vorgefilterten Suche.

Am meisten referenzierte anti-TNFRSF10A Antikörper

  1. Human Monoclonal TNFRSF10A Primary Antibody für CyTOF, FACS - ABIN252683 : Sridhar, Ali, Liang, El Etreby, Lewis, Kumar: Differential expression of members of the tumor necrosis factor alpha-related apoptosis-inducing ligand pathway in prostate cancer cells. in Cancer research 2001 (PubMed)
    Zeige alle 20 Referenzen für 252683

  2. Human Monoclonal TNFRSF10A Primary Antibody für FACS - ABIN4896694 : Hong, Kim, Kim, Ha, Kim, Bae, Kim, Lee, Kim: Smad7 protein induces interferon regulatory factor 1-dependent transcriptional activation of caspase 8 to restore tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis. in The Journal of biological chemistry 2013 (PubMed)
    Zeige alle 13 Referenzen für 4896694

  3. Human Monoclonal TNFRSF10A Primary Antibody für ICC, IF - ABIN252489 : Cisternas, Moreno: Comparative analysis of apoptotic pathways in rat, mouse, and hamster spermatozoa. in Molecular reproduction and development 2006 (PubMed)
    Zeige alle 7 Referenzen für 252489

  4. Human Monoclonal TNFRSF10A Primary Antibody für IP, WB - ABIN1106159 : Chen, Liu, Yue, Schönthal, Khuri, Sun et al.: CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of ... in Molecular pharmacology 2007 (PubMed)
    Zeige alle 3 Referenzen für 1106159

  5. Human Polyclonal TNFRSF10A Primary Antibody für WB - ABIN3042972 : Liu, Zuo, Wang, Chen, Yang, Wang, Zhu: miR-942 decreases TRAIL-induced apoptosis through ISG12a downregulation and is regulated by AKT. in Oncotarget 2014 (PubMed)
    Zeige alle 3 Referenzen für 3042972

  6. Human Monoclonal TNFRSF10A Primary Antibody für CyTOF, FACS - ABIN4361745 : Sarkar, Faller: Telomere-homologous G-rich oligonucleotides sensitize human ovarian cancer cells to TRAIL-induced growth inhibition and apoptosis. in Nucleic acid therapeutics 2013 (PubMed)

  7. Human Monoclonal TNFRSF10A Primary Antibody für FACS - ABIN1106162 : Mérino, Lalaoui, Morizot, Schneider, Solary, Micheau: Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2. in Molecular and cellular biology 2006 (PubMed)

  8. Human Polyclonal TNFRSF10A Primary Antibody für WB - ABIN657625 : Shimada, Miyagawa, Kawashima, Tanaka, Honda, Honda, Tokunaga: An approach based on a genome-wide association study reveals candidate loci for narcolepsy. in Human genetics 2010 (PubMed)

Weitere Antikörper gegen TNFRSF10A Interaktionspartner

Human Tumor Necrosis Factor Receptor Superfamily, Member 10a (TNFRSF10A) Interaktionspartner

  1. BAY61-3606 sensitizes colon cancer cells to TRAIL-induced apoptosis by up-regulating DR4 (zeige HLADRB4 Antikörper) expression in p53 (zeige TP53 Antikörper)-dependent manner and inhibiting NF-kappaB (zeige NFKB1 Antikörper) activity.

  2. findings together highlight a previously undiscovered mechanism that positively regulates DR4 (zeige HLADRB4 Antikörper) expression through activation of the MEK (zeige MAP2K1 Antikörper)/ERK (zeige EPHB2 Antikörper)/AP-1 (zeige FOSB Antikörper) signaling pathway.

  3. results suggest that the altered TRAIL, DR4 (zeige HLADRB4 Antikörper) alleles and sTRAIL levels may be associated with some other potential biomarkers for vitiligo (zeige MITF Antikörper)

  4. The nanovectorization of TRAIL enhanced its binding to both DR4 (zeige HLADRB4 Antikörper) and DR5 (zeige TNFRSF10B Antikörper) receptors at 37 degrees C and could potentially sensitized cancer cells to TRAIL induced apoptosis through simultaneous activation of DR4 (zeige HLADRB4 Antikörper) and DR5 (zeige TNFRSF10B Antikörper) as described in this paper for the non-small lung carcinoma cell line (H1703), the two hepatocarcinoma cell lines (SK-Hep1, HUH) and the colon carcinoma cell line (HCT116WT).

  5. Pro-survival effects by NF-kappaB (zeige NFKB1 Antikörper), Akt (zeige AKT1 Antikörper) and ERK(1 (zeige MAPK3 Antikörper)/2) and anti-apoptosis actions by Six1 (zeige SIX1 Antikörper) disrupt apoptotic functions of TRAIL-Dr4 (zeige HLADRB4 Antikörper)/5 pathway in ovarian cancer, which may explain why up-regulated DR4 (zeige HLADRB4 Antikörper) and DR5 (zeige TNFRSF10B Antikörper) in ovarian cancer are associated with poor prognosis and low survival ratio of the patients.

  6. Bee venom inhibits colon cancer cell growth, and these anti-proliferative effects may be related to the induction of apoptosis by activation of DR4 (zeige HLADRB4 Antikörper) and DR5 (zeige TNFRSF10B Antikörper) and inhibition of NF-kappaB (zeige NFKB1 Antikörper) activity.

  7. study involving a relatively large sample size showed that TNFRSF10 eQTL (zeige EQTN Antikörper) SNPs within lncRNAs might influence both hepatocellular carcinoma development and HBV infection

  8. Study investigated the association between colorectal cancer and polymorphisms in TRAIL and DR4 (zeige HLADRB4 Antikörper) gene in Pakistani patients; TRAIL gene 1595 C>T genotypes percentage in colorectal cancer patients was statistically non-significant; for DR4 (zeige HLADRB4 Antikörper) A1322G, homozygous GG genotype was 36% in the patients and in controls: there was statistically insignificant difference (p> 0.05).

  9. TRAIL genetic polymorphisms do not contribute, but DR4 (zeige HLADRB4 Antikörper) polymorphisms may contribute to susceptibility to head and neck cancer in Pakistani population.

  10. The structure of death receptor 4 (DR4) in complex with TNF-related apoptosis-inducing ligand (TRAIL (zeige TNFSF10 Antikörper)) has been determined at 3 A resolution and compared with those of previously determined DR5 (zeige TNFRSF10B Antikörper)-TRAIL complexes.

TNFRSF10A Antigen-Profil

Beschreibung des Gens

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is activated by tumor necrosis factor-related apoptosis inducing ligand (TNFSF10/TRAIL), and thus transduces cell death signal and induces cell apoptosis. Studies with FADD-deficient mice suggested that FADD, a death domain containing adaptor protein, is required for the apoptosis mediated by this protein.

Alternative names and synonyms associated with TNFRSF10A

  • tumor necrosis factor receptor superfamily, member 10a (TNFRSF10A) Antikörper
  • APO2 Antikörper
  • CD261 Antikörper
  • DR4 Antikörper
  • TNFRSF10A Antikörper
  • TRAILR-1 Antikörper
  • TRAILR1 Antikörper

Bezeichner auf Proteinebene für TNFRSF10A

TNF-related apoptosis-inducing ligand receptor 1 , TRAIL receptor 1 , TRAIL-R1 , cytotoxic TRAIL receptor , death receptor 4 , tumor necrosis factor receptor superfamily member 10A , tumor necrosis factor receptor superfamily member 10a variant 2 , tumor necrosis factor receptor superfamily, member 10a , tumor necrosis factor receptor superfamily member 10A-like

GENE ID SPEZIES
8797 Homo sapiens
510798 Bos taurus
716826 Macaca mulatta
743159 Pan troglodytes
100134832 Sus scrofa
100461502 Pongo abelii
100602881 Nomascus leucogenys
Ausgewählte Anbieter für anti-TNFRSF10A (TNFRSF10A) Antikörper
Haben Sie etwas anderes gesucht?